The ADAPT learning cancer treatment system: ARPA-H's initiative to revolutionize cancer therapy. Read more about The ADAPT learning cancer treatment system: ARPA-H's initiative to revolutionize cancer therapy.
Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct patterns and potential markers of progression. Read more about Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct patterns and potential markers of progression.
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer. Read more about Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer.
Small-molecule RNA therapeutics to target prostate cancer. Read more about Small-molecule RNA therapeutics to target prostate cancer.
Effective targeting of PDGFRA-altered high-grade glioma with avapritinib. Read more about Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.
Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtyping. Read more about Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtyping.
Elucidating acquired PARP inhibitor resistance in advanced prostate cancer. Read more about Elucidating acquired PARP inhibitor resistance in advanced prostate cancer.
Integrating priorities at the intersection of cancer and neuroscience. Read more about Integrating priorities at the intersection of cancer and neuroscience.
Glioblastoma induces the recruitment and differentiation of dendritic-like "hybrid" neutrophils from skull bone marrow. Read more about Glioblastoma induces the recruitment and differentiation of dendritic-like "hybrid" neutrophils from skull bone marrow.
